{"filing":{"accession_number":"0001193125-26-387190","cik":"0001792267","ticker":"BNR","company_name":"Burning Rock Biotech Ltd","form":"6-K","filing_date":"2026-09-10","report_date":"2026-09-10","primary_document":"d76318d6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1792267/000119312526387190/d76318d6k.htm"},"events":[{"id":32506,"run_id":29870,"accession_number":"0001193125-26-387190","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a press release announcing Burning Rock's second quarter 2026 financial results, dated September 10, 2026. The exhibit discloses Q2 2026 revenues (RMB134.7 million, down 9.3% YoY), net loss (RMB18.4 million vs. RMB9.7 million in Q2 2025), gross profit, operating expenses, and cash position, along with selected operating data and balance sheet information. The disclosure is material as it reports quarterly financial performance and includes business updates on regulatory approvals for key products entering priority review channels.","company_name":"Burning Rock Biotech Ltd","ticker":"BNR","filing_date":"2026-09-10","form":"6-K","submitted_at":null,"items":[{"id":35695,"accession_number":"0001193125-26-387190","item_number":"EX-99.1","item_title":"d76318dex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a press release announcing Burning Rock's second quarter 2026 financial results, dated September 10, 2026. The exhibit discloses Q2 2026 revenues (RMB134.7 million, down 9.3% YoY), net loss (RMB18.4 million vs. RMB9.7 million in Q2 2025), gross profit, operating expenses, and cash position, along with selected operating data and balance sheet information. The disclosure is material as it reports quarterly financial performance and includes business updates on regulatory approvals for key products entering priority review channels.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-10T11:03:48.674026+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35695,"accession_number":"0001193125-26-387190","item_number":"EX-99.1","item_title":"d76318dex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a press release announcing Burning Rock's second quarter 2026 financial results, dated September 10, 2026. The exhibit discloses Q2 2026 revenues (RMB134.7 million, down 9.3% YoY), net loss (RMB18.4 million vs. RMB9.7 million in Q2 2025), gross profit, operating expenses, and cash position, along with selected operating data and balance sheet information. The disclosure is material as it reports quarterly financial performance and includes business updates on regulatory approvals for key products entering priority review channels.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-10T11:03:48.674026+00:00","company_name":"Burning Rock Biotech Ltd","ticker":"BNR","filing_date":"2026-09-10"}]}